Innovent Biologics, Inc. (1801.HK)

HKD 36.2

(-0.82%)

Net Debt Summary of Innovent Biologics, Inc.

Innovent Biologics, Inc.'s latest annual net debt in 2023 was 874.83 Million CNY , down -60.46% from previous year.
Innovent Biologics, Inc.'s latest quarterly net debt in 2023 FY was 874.83 Million CNY , down -60.46% from previous quarter.
Innovent Biologics, Inc. reported annual net debt of 2.21 Billion CNY in 2022, up 94.49% from previous year.
Innovent Biologics, Inc. reported annual net debt of 1.13 Billion CNY in 2021, up 1734.13% from previous year.
Innovent Biologics, Inc. reported quarterly net debt of 874.83 Million CNY for 2023 Q4, up 113.55% from previous quarter.
Innovent Biologics, Inc. reported quarterly net debt of 874.83 Million CNY for 2023 FY, down -60.46% from previous quarter.

Annual Net Debt Chart of Innovent Biologics, Inc. (2023 - 2016)

Historical Annual Net Debt of Innovent Biologics, Inc. (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	874.83 Million CNY	-60.46%
2022	2.21 Billion CNY	94.49%
2021	1.13 Billion CNY	1734.13%
2020	-69.61 Million CNY	95.54%
2019	-1.56 Billion CNY	58.2%
2018	-3.73 Billion CNY	-792543.74%
2017	-471 Thousand CNY	99.91%
2016	-512.99 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2023 Q2	2.12 Billion CNY	150.11%
2023 Q4	874.83 Million CNY	113.55%
2023 FY	874.83 Million CNY	-60.46%
2023 Q3	-6.45 Billion CNY	-404.56%
2023 Q1	-4.23 Billion CNY	-291.22%
2022 Q1	-5.56 Billion CNY	-589.47%
2022 FY	2.21 Billion CNY	94.49%
2022 Q3	-5.96 Billion CNY	-521.53%
2022 Q2	1.41 Billion CNY	125.4%
2022 Q4	2.21 Billion CNY	137.12%
2021 Q3	-5.9 Billion CNY	-126.28%
2021 FY	1.13 Billion CNY	1734.13%
2021 Q1	-9.32 Billion CNY	-13292.86%
2021 Q2	-2.6 Billion CNY	72.02%
2021 Q4	1.13 Billion CNY	119.27%
2020 Q1	-3.67 Billion CNY	-135.65%
2020 Q3	-6.57 Billion CNY	-79.48%
2020 Q2	-3.66 Billion CNY	0.42%
2020 Q4	-69.61 Million CNY	98.94%
2020 FY	-69.61 Million CNY	95.54%
2019 FY	-1.56 Billion CNY	58.2%
2019 Q4	-1.56 Billion CNY	53.87%
2019 Q3	-3.38 Billion CNY	-29.75%
2019 Q2	-2.6 Billion CNY	0.27%
2019 Q1	-2.61 Billion CNY	29.97%
2018 Q1	2.36 Billion CNY	501162.0%
2018 Q3	-3.73 Billion CNY	-213.7%
2018 FY	-3.73 Billion CNY	-792543.74%
2018 Q4	-3.73 Billion CNY	0.0%
2018 Q2	-1.19 Billion CNY	-150.43%
2017 Q3	3.05 Billion CNY	0.0%
2017 Q1	1.79 Billion CNY	0.0%
2017 Q4	-471 Thousand CNY	-100.02%
2017 FY	-471 Thousand CNY	99.91%
2016 FY	-512.99 Million CNY	0.0%

Peer Net Debt Comparison of Innovent Biologics, Inc.

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	1245.538%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	83.39%